{'fraction_non_alphanumeric': 0.032879818594104306, 'fraction_numerical': 0.030612244897959183, 'mean_word_length': 5.26241134751773, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Analgesic and anti-inflammatory efficacy of biarison. Clinical experimental studies (author's transl)].

The analgesic time-effect profile of 600 mg Biarison (clinical experimental number: RU 43-715) compared with 100 mg indometacin, placebo and a blank test was recorded for 12 healthy subjects as an intra-individual single-blind trial by means of electrical measurement of thresholds in the teeth. Biarison shows a powerful analgesic effect with a maximum increase of the threshold by 22.3 mA after 75 minutes. The maximum increase in mA with indometacin and placebo was 18 and 9 mA respectively. The differences are confirmed statistically. Under double blind conditions, no significant differences in antiphlogistic activity could be established between Biarison (900 mg/day) and indometacin (150 mg/day) with reference to the edema appearing after maxillary sinus operations.